$1.38
-0.01[-0.72%]
At close: May 2
$1.38
0[0.00%]
After Hours: 7:59PM EDT
Latest News for Ocugen Stock (NASDAQ:OCGN)
Ocugen Stock (NASDAQ: OCGN)
Categories: All
Monday, April 29, 2024
- Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - 3 days ago
- Ocugen Announces OCU400, Modifier Gene Therapy, Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024Benzinga Newsdesk - 3 days ago
Friday, April 26, 2024
Monday, April 22, 2024
Friday, April 19, 2024
Wednesday, April 10, 2024
Monday, April 08, 2024
- Why Ocugen Shares Are Trading HigherHenry Khederian - Apr 8, 2024, 11:08AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Apr 8, 2024, 8:09AM
- Ocugen shares are trading higher after the company announced U.S. FDA clearance of the IND amendment to initiate a Phase 3 clinical trial of OCU400.Benzinga Newsdesk - Apr 8, 2024, 7:47AM
- Ocugen Reveals US FDA Clearance Of IND Amendment To Begin OCU400 Phase 3 Clinical Trial - First Gene Therapy To Enter Phase 3 With Broad Retinitis Pigmentosa IndicationBenzinga Newsdesk - Apr 8, 2024, 6:34AM
Friday, April 05, 2024
- Why Ocugen Stock Is Climbing TodayErica Kollmann - Apr 5, 2024, 3:56PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Apr 5, 2024, 12:31PM
- Ocugen shares are trading higher after the company announced the Data and Safety Monitoring Board for the Phase 1/2 ArMaDa clinical trial for OCU410 recently approved to proceed dosing with the medium dose of OCU410 in the dose-escalation phase of the study.Benzinga Newsdesk - Apr 5, 2024, 7:18AM
- Ocugen Announces Positive Data And Safety Monitoring Board Review And Initiation Of Enrollment In Medium Dose For OCU410, A Modifier Gene Therapy, In Phase 1/2 ArMaDa Study For Geographic AtrophyBenzinga Newsdesk - Apr 5, 2024, 7:06AM
Wednesday, April 03, 2024
- Why Ocugen Shares Are Popping OffHenry Khederian - Apr 3, 2024, 11:44AM
- Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Apr 3, 2024, 10:31AM
- HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $7 Price TargetBenzinga Newsdesk - Apr 3, 2024, 6:46AM
Tuesday, April 02, 2024
- Ocugen shares are trading lower. The company provided a general business update with certain financials for the year ending 2023.Benzinga Newsdesk - Apr 2, 2024, 11:34AM
- Ocugen Reports $39.5M In Cash, Cash Equivalents As Of Dec. 31, 2023Benzinga Newsdesk - Apr 2, 2024, 8:06AM
- Earnings Scheduled For April 2, 2024Benzinga Insights - Apr 2, 2024, 6:25AM
- Reported Earlier, Ocugen OCU410ST Advances In GARDian Study For Stargardt Disease With DSMB Approval For Medium Dose EnrollmentBenzinga Newsdesk - Apr 2, 2024, 2:32AM
Monday, April 01, 2024
Tuesday, March 26, 2024
Monday, March 25, 2024
Friday, March 22, 2024
- Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 22, 2024, 2:39PM
- Ocugen shares are trading higher after the Third Circuit Court of Appeals upheld the decision of the Eastern District of Pennsylvania to dismiss with prejudice the consolidated securities class action lawsuits against Ocugen.Benzinga Newsdesk - Mar 22, 2024, 2:20PM
- Reported March 21, Third Circuit Court Of Appeals Upheld Decision Of Eastern District Of Pennsylvania To Dismiss With Prejudice Consolidated Securities Class Action Lawsuits Against OcugenBenzinga Newsdesk - Mar 22, 2024, 1:58PM
- Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On FridayAvi Kapoor - Mar 22, 2024, 10:08AM
- Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 22, 2024, 8:10AM
Thursday, March 21, 2024
Wednesday, March 13, 2024
Monday, February 26, 2024
Thursday, February 22, 2024
- Ocugen, Inc. Announces Dosing Completion Of Subjects With Stargardt In Cohort 1 Of Phase 1/2 Clinical Trial Evaluating The Safety And Efficacy Of OCU410STHappy Mohamed - Feb 22, 2024, 4:34PM
- HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $7 Price TargetBenzinga Newsdesk - Feb 22, 2024, 6:46AM
Wednesday, February 21, 2024
Tuesday, February 20, 2024
- Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 20, 2024, 1:21PM
- Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Feb 20, 2024, 8:09AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Feb 20, 2024, 8:05AM